Ftse Mib
34.657,35
0,93%
DAX
18.772,85
0,50%
S&P 500
5.222,68
0,16%
NASDAQ
16.340,87
-0,03%
Bitcoin
61.080,75
0,47%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Avalon Pharmaceuticals (MM) (AVRX) Avalon Pharmaceuticals (MM) (AVRX) Notizie

AVRX

Avalon (AVRX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AVRX
DataOraFonteTitoloSimboloCompagnia
13/05/200921:39Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
06/05/200922:48Edgar (US Regulatory)Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
06/05/200922:46Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
28/04/200922:49Business WireAvalon Pharmaceuticals Announces Special Meeting DateNASDAQ:AVRXAvalon Pharmaceuticals (MM)
07/04/200921:00Business WireAvalon Pharmaceuticals Receives Audit Opinion Containing Going Concern StatementNASDAQ:AVRXAvalon Pharmaceuticals (MM)
17/03/200920:00Business WireAvalon Pharmaceuticals Receives Staff Determination Regarding Nasdaq DelistingNASDAQ:AVRXAvalon Pharmaceuticals (MM)
10/03/200921:07Edgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
11/02/200922:11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
10/02/200923:04Edgar (US Regulatory)Statement of Ownership (SC 13G)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
22/12/200822:23Business WireAvalon Pharmaceuticals Receives Extension of Time to Comply with NASDAQ Deficiency NoticeNASDAQ:AVRXAvalon Pharmaceuticals (MM)
25/11/200820:18Business WireAvalon Pharmaceuticals Receives NASDAQ Deficiency NoticeNASDAQ:AVRXAvalon Pharmaceuticals (MM)
07/11/200822:04Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (D)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
05/11/200822:29Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
28/10/200813:26Business WireClinical Data, Inc. to Acquire Avalon PharmaceuticalsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
29/09/200821:16Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Current report filing (8-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
26/09/200822:16Business WireAvalon Pharmaceuticals Receives Nasdaq Deficiency NoticeNASDAQ:AVRXAvalon Pharmaceuticals (MM)
26/08/200817:02Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
14/08/200817:53Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Quarterly Report (10-Q)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
13/08/200816:00Business WireAvalon Pharmaceuticals Reports Second Quarter 2008 ResultsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
05/08/200815:00Business WireAvalon Pharmaceuticals Sets Second Quarter 2008 Conference Call DateNASDAQ:AVRXAvalon Pharmaceuticals (MM)
24/07/200818:07Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Amended Current report filing (8-K/A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
18/07/200820:23Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Confidential Treatment Order (CT ORDER)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
26/06/200814:00Business WireAvalon Pharmaceuticals Nominates Lead Clinical Development Candidate in its Beta-catenin Pathway Inhibitor ProgramNASDAQ:AVRXAvalon Pharmaceuticals (MM)
07/05/200822:20Business WireAvalon Pharmaceuticals Reports First Quarter 2008 ResultsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
30/04/200814:00Business WireAvalon Pharmaceuticals to Release First Quarter 2008 ResultsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
29/04/200815:54Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Proxy Statement (definitive) (DEF 14A)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
14/04/200817:00Business WireAvalon Pharmaceuticals Identifies Small Molecule Inhibitors of the Aurora/Centrosome Cancer Pathway that Block PLK3 Protein FuncNASDAQ:AVRXAvalon Pharmaceuticals (MM)
31/03/200820:34Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Annual Report (10-K)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
19/03/200821:15Business WireAvalon Pharmaceuticals Reports Fourth Quarter and Full Year 2007 ResultsNASDAQ:AVRXAvalon Pharmaceuticals (MM)
17/03/200820:57Edgar (US Regulatory)Avalon Pharmaceuticals Inc - Initial Statement of Beneficial Ownership (3)NASDAQ:AVRXAvalon Pharmaceuticals (MM)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AVRX

La tua Cronologia

TSX
BN.PR.R
Brookfield
LSE
FDEV
Frontier Developments
COIN
QAUUSD
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network